Population pharmacokinetics of rituximab with or without plasmapheresis in kidney patients with antibody-mediated disease

AIMS: Both rituximab and plasmapheresis can be associated in the treatment of immune-mediated kidney diseases. The real impact of plasmapheresis on rituximab pharmacokinetics is unknown. The aim of this study was to compare rituximab pharmacokinetics between patients requiring plasmapheresis and oth...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Puisset, Florent, White-Koning, Mélanie, Kamar, Nassim, Huart, Antoine, Haberer, Frédérique, Blasco, Hélène, Le Guellec, Chantal, Lafont, Thierry, Grand, Anaïs, Rostaing, Lionel, Chatelut, Etienne, Pourrat, Jacques
Materialtyp: Artigo
Språk:Inglês
Publicerad: Blackwell Science Inc 2013
Ämnen:
Pharmacokinetics
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3853532/
https://ncbi.nlm.nih.gov/pubmed/23432476
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12098
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk